Ms. Carolyn Renee Bulmash, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6800 Joliet Rd, Indianhead Park, IL 60525 Phone: 708-246-8500 |
News Archive
Amorfix Life Sciences and Epitomics, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS(TM) computational platform discovery technology, which will be used by Epitomics to generate highly specific monoclonal antibodies (mAbs).
Modern Healthcare: As part of the new health law, HHS is distributing $68 million in grants "to help people navigate their health and long-term-care options. The grants will be going to states, territories, tribal and community-based organizations to help seniors, individuals with disabilities and caregivers make more-informed decisions about their health and long-term care.
The March journal also includes a study that found a link between high levels of persistent organic pollutants (POPs) in a person's bloodstream and insulin resistance, a precursor for type 2 diabetes.
Targeted Genetics Corporation (the "Company") today announced that it has determined that the expense and management attention required for NASDAQ Capital Market and Securities and Exchange Commission ("SEC") compliance outweigh the benefits for the Company and its shareholders at this time.
Affymetrix, Inc. announced today that the Institute for Pharmacogenomics and Individualized Therapy (IPIT) at the University of North Carolina in Chapel Hill is using the company's DMETâ„¢ Plus biomarker panel to expand the Pharmacogenetics for Every Nation Initiative (PGENI).
› Verified 2 days ago